You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
平安好醫生(01833.HK)止跌彈逾半成發佈戰略級新產品
阿思達克 06-10 12:06

平安好醫生(01833.HK)發佈戰略級新產品,推出「私人醫生」新服務及建立醫患深厚關係。該股扭七連跌,由近五個月低位回升,最高見33.9元,半日收33.85元,反彈5.3%,半日成交額1,559萬元。

平安好醫生公布,推出戰略新產品「平安好醫生私人醫生」,為超過2億新中產人群打造的全方位、高品質的醫療健康服務,提供包括健康管理、即時問診諮詢、名醫二診和線下門診就醫安排等一站式醫療健康服務。公司指,通過創新私人醫生服務模式,能讓醫生與用戶全方位互動,醫生可以長期追蹤用戶健康狀況,雙方像是熟人般緊密聯繫並建立深厚信任關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account